Henry Schein, Inc. (OQ:HSIC)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 135 Duryea Rd
MELVILLE NY 11747
Tel: 1-631-8435963
Website: https://www.henryschein.com
IR: See website
<
Key People
Stanley M. Bergman
Chairman of the Board, Chief Executive Officer, Director
Christopher Pendergast
Senior Vice President, Chief Technology Officer
James P. Breslawski
President, Vice Chairman of the Board, Director
Andrea Albertini
President - International Distribution Group
David Brous
Chief Executive Officer, Strategic Business Group
Brad Connett
Chief Executive Officer, North American Distribution Group
Rene Willi
Chief Executive Officer, Global Oral Reconstruction Group
Michael S. Ettinger
Chief Operating Officer, Executive Vice President
Lorelei Mcglynn
Senior Vice President, Chief Human Resource Officer
Mark E. Mlotek
Chief Strategic Officer, Executive Vice President, Director
   
Business Overview
Henry Schein, Inc. is a solutions company for health care professionals. The Company's business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work to provide quality care. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. The Company's Health Care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products, diagnostic tests, infection-control products, personal protective equipment products (PPE) and vitamins. Its Technology and Value-added services segment provide software, technology and other value-added services to healthcare practitioners. The Company also operates as a supplier of homecare medical products delivered directly to patients in their homes.
Financial Overview
For the 39 weeks ended 30 September 2023, Henry Schein, Inc. revenues increased less than 1% to $9.32B. Net income decreased 19% to $398M. Revenues reflect Technology and value-added services segment increase of 11% to $594M, International segment increase of 9% to $2.44B, also reflect Dental segment decrease of 13% to $4.74B, Medical segment decrease of 9% to $2.99B, North America segment decrease of 2% to $6.89B.
Employees: 25,000 as of Dec 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $11,170M as of Dec 30, 2023
Annual revenue (TTM): $12,339M as of Dec 30, 2023
EBITDA (TTM): $992.00M as of Dec 30, 2023
Net annual income (TTM): $416.00M as of Dec 30, 2023
Free cash flow (TTM): $313.00M as of Dec 30, 2023
Net Debt Last Fiscal Year: $2,180M as of Dec 30, 2023
Shares outstanding: 128,481,162 as of Mar 22, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.